What matters

The Federal Motor Carrier Safety Administration announced exemptions allowing 16 individuals with seizure histories who take anti-seizure medication to operate commercial motor vehicles in interstate commerce. Its November 4, 2026, notice gives an applicability date of July 27, 2026, and an expiration date of July 27, 2028. The permissions are individual and remain subject to earlier revocation.

Verified facts

  • FMCSA announced exemptions for 16 individuals from the federal medical standard concerning epilepsy or other conditions likely to cause loss of consciousness or loss of control of an interstate commercial motor vehicle.
  • According to FMCSA, the exemptions allow these recipients, who have had one or more seizures and take anti-seizure medication, to operate commercial motor vehicles in interstate commerce.
  • FMCSA states that the exemptions became applicable on July 27, 2026, and are scheduled to expire on July 27, 2028.
  • FMCSA says the 16 applicants maintained stable medication regimens for the preceding two years. Each applicant’s treating physician verified the seizure history and supported the applicant’s ability to drive commercially.
  • Each exemption lasts two years from its effective date unless FMCSA revokes it earlier. The agency lists failure to comply with exemption terms and conditions among the grounds for revocation.

Analysis

The notice concerns permission for the 16 recipients, not a general exemption for drivers with seizure histories. Its publication date is distinct from the stated applicability date. The July 2028 expiration describes the scheduled duration; the possibility of earlier revocation limits that duration.

Editorial opinion

VERXERA opinion: The evidence supports reading this as a limited, conditional authorization for 16 drivers, rather than a general change in eligibility. The July 27, 2026–July 27, 2028 period establishes a two-year permission, while FMCSA’s account of two years of stable medication regimens and treating-physician support describes the medical circumstances behind these individual exemptions. Connecting those facts matters because the permission and its medical basis should be understood together, not as interchangeable claims about every driver with a seizure history. The strongest limitation is that a scheduled expiration is not a guarantee of uninterrupted authorization: FMCSA may revoke an exemption earlier. Deeper reading is worthwhile for understanding the individual permissions and their conditions, not for drawing broader conclusions about driving eligibility.

This is VERXERA’s editorial interpretation, separated from the facts and analysis above. The reader keeps the final judgment.

Counterevidence and limits

The exemptions are conditional, and FMCSA can revoke them before their scheduled expiration, including for failure to comply with their terms.

Known uncertainties

Whether each exemption will remain in effect until July 27, 2028, depends on compliance with its conditions and any earlier FMCSA revocation.